Five-year Overview
In thousands of CHF |
2023 |
2022 |
2021 |
2020 |
2019 |
| Net sales | 397,453 | 586,395 | 513,721 | 395,816 | 371,606 |
| Operating income | 24,978 | 98,975 | 84,085 | 39,329 | 19,939 |
| In % of net sales | 6,3% | 16,9% | 16,4% | 9,9% | 5,4% |
| EBITDA | 44,996 | 118,913 | 102,749 | 58,616 | 39,974 |
| In % of net sales | 11,3% | 20,3% | 20,0% | 14,8% | 10,8% |
| Net income | 15,388 | 78,109 | 67,437 | 27,661 | 12,027 |
| In % of net sales | 3,9% | 13,3% | 13,1% | 7,0% | 3,2% |
| Free cash flow1 | -584 | 42,173 | 57,767 | 41,649 | 30,112 |
| In % of net sales | -0,1% | 7,2% | 11,2% | 10,5% | 13,1% |
| Total assets | 473,578 | 556,801 | 482,341 | 429,271 | 391,710 |
| Shareholders' equity | 296,092 | 331,532 | 274,981 | 214,956 | 195,948 |
| In % of total assets | 62,5% | 59,5% | 57,0% | 50,1% | 50,0% |
| Number of employees (year-end) | |||||
| Switzerland | 586 | 647 | 565 | 474 | 494 |
| International | 991 | 1,116 | 1,006 | 929 | 836 |
| Total | 1,577 | 1,763 | 1,571 | 1,403 | 1,330 |
1 Net cash provided by operating activities and net cash (used in) investing activities, as per consolidated statement of cash flows.
Segments
2019
| in TCHF |
Industrial X-Ray |
ebeam Technologies (EBT) |
Plasma Control Technologies (PCT) |
X-Ray Systems (IXS) |
Elimination of intersegment sales |
Corporate | Total Group | |
|---|---|---|---|---|---|---|---|---|
| Net sales | ||||||||
| External sales | 65’045 | 15'481 | 151’734 | 139'346 | - | - | 371’606 | |
| Intersegment sales | 13'095 | - | - | 205 | -13’301 | - | - | |
| Total net sales | 78’141 | 15’481 | 151’734 | 139'551 | -13'301 | - | 371’606 | |
| Earnings | ||||||||
| Segment operating income/loss | 16'338 | -7’903 | 8’206 | 6’301 | -473 | - | 22’468 | |
| Unallocated costs | - | - | - | - | - | -2’530 | -2’530 | |
| Operating Income | 16’338 | -7’903 | 8’206 | 6’301 | -473 | -2’530 | 19’939 | |
| Financing expenses | -6’738 | |||||||
| Financing income | 2’162 | |||||||
| Income before tax | 15’363 | |||||||
| Income tax | -3’336 | |||||||
| Net income | 12’027 | |||||||
| EBITDA | 21’742 | -6’156 | 15’366 | 12’026 | -473 | -2'530 | 39’974 | |
| EBITDA in % of sales | 27.8% | -39.8% | 10.1% | 8.6% | 10.8% | |||
| Assets and liabilities | ||||||||
| Segment assets | 82’941 | 16’801 | 109’507 | 112’813 | - | 69’648 | 391’710 | |
| Segment liabilities | -15’610 | -6’164 | -31’904 | -66’320 | - | -75’764 | -195’762 | |
| Net assets | 67’331 | 10’637 | 77’603 | 46’493 | - | -6’116 | 195’948 | |
| Other segment information | ||||||||
| Depreciation and amortization | 5’404 | 1’746 | 7’160 | 5’725 |
-
|
-
|
20’035 | |
| Capital expenditure | 4’474 | 860 | 7’855 | 8’003 | - | - | 21’194 | |
| Change in provisions | -152 | 151 | -2’080 | -482 | - | - | -2’563 | |
| Other non-cash expense/income | -623 | 420 | 1'104 | -58 | 38 | 162 | 1'044 | |
| Number of employees at year-end | 279 | 68 | 544 | 439 | - | - | 1'330 |
Segments
2020
| in TCHF | Industrial X-Ray Modules (IXM) |
Plasma Control Technologies (PCT) |
X-Ray Systems (IXS) |
ebeam Technologies (EBT) |
Elimination of intersegment sales |
Corporate | Total Group |
|---|---|---|---|---|---|---|---|
Net sales |
|||||||
| External sales | 57,120 | 137,586 | 120,851 | 16,879 |
-
|
-
|
332,437 |
| Intersegment sales | 12,498 |
-
|
595 |
-
|
-13,093 |
-
|
-
|
| Total net sales | 69,618 | 137,586 | 121,446 | 16,879 | -13,093 |
-
|
332,437 |
Earnings |
|||||||
| Segment operating income/loss | 13,079 | 27,772 | 8,676 | -10,991 | -194 |
-
|
38,342 |
| Unallocated costs |
-
|
-
|
-
|
-
|
-1,870 | -1,870 | |
| Operating income | 13,079 | 27,772 | 8,676 | -10,991 | -194 | -1,870 | 36,473 |
| Financing expenses | -6,333 | ||||||
| Financing income | 5,950 | ||||||
| Income before tax | 36,090 | ||||||
| Income tax | -8,754 | ||||||
| Net income | 27,336 | ||||||
EBITDA |
16,475 | 30,919 | 11,460 | -9,091 | -194 | -1,870 | 47,699 |
| EBITDA in % of sales | 23.7% | 22.5% | 9.4% | -53.9% | 14.3% | ||
Assets and liabilities |
|||||||
| Segment assets | 55,860 | 72,865 | 91,383 | 41,401 |
-
|
83,400 | 344,908 |
| Segment liabilities | -13,262 | -21,337 | -36,454 | -17,398 |
-
|
-80,113 | -168,563 |
| Net assets | 42,598 | 51,528 | 54,930 | 24,003 |
-
|
3,287 | 176,346 |
Other segment information |
|||||||
| Capital expenditure | 4,800 | 2,814 | 1,852 | 9,706 |
-
|
-
|
19,171 |
| Depreciation and amortization | 3,396 | 3,147 | 2,783 | 1,900 |
-
|
-
|
11,226 |
| Change in provisions | -18 | 688 | 736 | 545 |
-
|
-118 | 1,834 |
| Other non-cash expense/(income) | -355 | -375 | 419 | 414 | 192 | -887 | -591 |
| Number of employees at year-end | 285 | 407 | 389 | 149 |
-
|
-
|
1,230 |
Segments
2021
In thousands of CHF |
Plasma Control Technologies (PCT) |
X-Ray Systems (IXS) |
Industrial X-Ray Modules (IXM) |
ebeam Technologies (EBT) |
Elimination of intersegment sales |
Corporate |
Consolidated |
Net sales |
|||||||
| External net sales | 306’091 | 138’371 | 69’259 | — | — | — | 513’721 |
| Intersegment sales | — | 535 | 9’687 | — | -10’222 | — | — |
| Total net sales | 306’091 | 138’906 | 78’946 | — | -10’222 | — | 513’721 |
Earnings |
|||||||
| Segment operating income |
71’864 | 3’634 | 10’548 | — | 294 | — | 86’340 |
| Unallocated costs | — | — | — | — | — | -2’255 | -2’255 |
Operating income |
71’864 | 3’634 | 10’548 | — | 294 | -2’255 | 84’085 |
| Financing expenses | -5’106 | ||||||
| Financing income | 3’229 | ||||||
| Income before tax | 82’208 | ||||||
| Income tax | -14’771 | ||||||
Net income |
67’437 | ||||||
EBITDA |
80’487 | 8’931 | 15’292 | — | 294 | -2’255 | 102’749 |
| EBITDA in % of net sales | 26.3% | 6.4% | 19.4% | 20.0% | |||
Assets and liabilities at Dec. 31, 2021 |
|||||||
| Segment assets | 153’907 | 116’142 | 85’470 | — | — | 134’897 | 490’415 |
| Segment liabilities | -50’890 | -75’497 | -20’290 | — | — | -68’757 | -215’435 |
Net assets |
103’017 | 40’645 | 65’180 | — | — | 66’140 | 274’981 |
Other segment information |
|||||||
| Expenditure for right-of-use asset | 1’165 | 861 | 1’597 | — | — | — | 3’623 |
| Expenditure for property, plant and equipment & intangible assets | 6’586 | 1’870 | 3’011 | — | — | — | 11’467 |
| Depreciation, amortization and impairment | 8’622 | 5’297 | 4’744 | — | — | — | 18’663 |
| Change in provisions | 262 | -1’887 | 77 | — | — | — | -1’549 |
| Other non-cash expense/(income) | -203 | -293 | -47 | — | 24 | 400 | -119 |
| Number of employees at year end | 826 | 435 | 310 | — | — | — | 1’571 |
Segments 2022
In thousands of CHF |
Plasma |
X-Ray |
Industrial |
Elimination |
Corporate |
Consolidated |
Net sales |
||||||
| External net sales | 381,424 | 129,944 | 75,026 | — | — | 586,395 |
| Intersegment sales | — | 407 | 13,616 | (14,023) | — | — |
Total net sales |
381,424 | 130,351 | 88,643 | (14,023) | — | 586,395 |
Segment operating income |
94,497 | (3,104) | 10,868 | (1,227) | — | 101,033 |
| Unallocated costs | — | — | — | — | (2,059) | (2,059) |
Operating income |
94,497 | (3,104) | 10,868 | (1,227) | (2,059) | 98,975 |
| lnterest income | — | — | — | — | — | 440 |
| lnterest (expenses) | — | — | — | — | — | (1,715) |
| Net gains or (losses) on derivative fair value | — | — | — | — | — | (192) |
| Net gains or (losses) on foreign exchange | — | — | — | — | — | (2,140) |
Income before tax |
— | — | — | — | — | 95,368 |
| lncome tax | — | — | — | — | — | (17,259) |
Net income |
— | — | — | — | — | 78,109 |
EBITDA |
104,915 | 1,607 | 15,677 | (1,227) | (2,059) | 118,913 |
| EBITDA in % of net sales | 27.5% | 1.2% | 17.7% | 20.3% | ||
Assets and liabilities at Dec. 31, 2022 |
||||||
| Segment assets | 216,730 | 103,496 | 88,108 | — | 148.467 | 556,801 |
| Segment liabilities | (75,364) | (53,689) | (17,222) | — | (78,994) | (225,269) |
Net assets |
141,365 | 49,807 | 70,886 | — | 69,473 | 331,532 |
Other segment information |
||||||
| Additions to right-of-use asset | 20,714 | 1,558 | 239 | — | — | 22,511 |
| Additions to property, plant and equipment & intangible assets | 16,958 | 2,384 | 3,412 | — | — | 22,753 |
| Depreciation, amortization and impairment | 10,419 | 4,711 | 4,809 | — | — | 19,939 |
| Change in provisions | (318) | 1,509 | (166) | — | — | 1,026 |
| Other non-cash expense or (income) | (345) | 93 | 4 | 58 | 24 | (166) |
| Number of employees at year-end | 998 | 430 | 335 | — | — | 1,763 |
Segments 2023
In thousands of CHF |
Plasma |
X-Ray |
Industrial |
Elimination |
Corporate |
Consolidated |
Net sales |
||||||
| External net sales | 193,155 | 116,826 | 87,472 | — | — | 397,453 |
| Intersegment sales | — | 134 | 12,787 | -12,921 | — | — |
Total net sales |
193,155 | 116,961 | 100,258 | -12,921 | — | 397,453 |
Segment operating income |
7,192 | 671 | 19,580 | 761 | — | 28,204 |
| Unallocated costs | — | — | — | — | -3,226 | -3,226 |
Operating income |
7,192 | 671 | 19,580 | 761 | -3,226 | 24,978 |
| lnterest income | — | — | — | — | — | 1,632 |
| lnterest (expenses) | — | — | — | — | — | -2,214 |
| Other financial expenses | — | — | — | — | — | -178 |
| Net gains on derivative fair value | — | — | — | — | — | 1,791 |
| Net losses on foreign exchange | — | — | — | — | — | -7,014 |
Income before tax |
— | — | — | — | — | 18,994 |
| lncome tax | — | — | — | — | — | -3,606 |
Net income |
— | — | — | — | — | 15,388 |
EBITDA |
18,719 | 4,923 | 23,819 | 761 | -3,226 | 44,996 |
| EBITDA in % of net sales | 9,7% | 4,2% | 23,8% | 11,3% | ||
Assets and liabilities at Dec. 31, 2023 |
||||||
| Segment assets | 181,421 | 95,340 | 88,105 | — | 108,713 | 473,578 |
| Segment liabilities | -52,386 | -44,018 | -14,854 | — | -66,228 | -177,486 |
Net assets |
129,035 | 51,321 | 73,252 | — | 42,484 | 296,092 |
Other segment information |
||||||
| Additions to right-of-use asset | 4,044 | 1,010 | 164 | — | — | 5,217 |
| Additions to property, plant and equipment & intangible assets | 19,224 | 3,282 | 3,907 | — | — | 26,413 |
| Depreciation, amortization and impairment | 11,527 | 4,252 | 4,239 | — | — | 20,018 |
| Change in provisions | -443 | -894 | 172 | — | — | -1,165 |
| Other non-cash expense or (income) | -74 | 463 | -44 | 104 | 1,945 | 2,394 |
| Number of employees at year-end | 787 | 463 | 327 | — | — | 1,577 |